Merit Financial Group’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$334K Buy
31,197
+7,920
+34% +$88.6K ﹤0.01% 1839
2026
Q2
$255K Buy
23,277
+9,708
+72% +$91.6K ﹤0.01% 1930
2026
Q1
$110K Sell
13,569
-8,930
-40% -$76.7K ﹤0.01% 2002
2025
Q4
$234K Buy
22,499
+12,454
+124% +$131K ﹤0.01% 1727
2025
Q3
$88.9K Buy
+10,045
New +$71.6K ﹤0.01% 1743

Other funds holding KURA

Merit Financial Group's KURA Position: Q3 2026 in Review

Merit Financial Group increased its Kura Oncology (KURA) stake by 34% in Q3 2026, buying an estimated $88.6K and bringing the position to 31,197 shares worth $334K. The position accounts for ﹤0.01% of the portfolio, ranked #1839.

Merit Financial Group first reported a position in KURA in Q3 2025 and has held it in 5 quarters since. 229 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • Merit Financial Group held 31,197 shares of Kura Oncology worth $334K as of Q3 2026.
  • Merit Financial Group bought 7,920 Kura Oncology shares in Q3 2026, an estimated $88.6K.
  • Kura Oncology made up ﹤0.01% of Merit Financial Group's portfolio in Q3 2026, its #1839 holding.
  • Merit Financial Group first reported a position in Kura Oncology in Q3 2025 and has held it in 5 quarters since.
  • 229 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on Merit Financial Group's 13F filing for Q3 2026, filed 6 Nov 2026.